Ebola vaccine trial to start in DR Congo as warning issued over speed of infections

According to the BBC, health authorities are preparing to launch an Ebola vaccine trial in the Democratic Republic of Congo following a concerning surge in infection rates. The World Health Organization (WHO) has issued a formal warning regarding the rapid spread of the virus, noting that the speed of transmission has accelerated significantly in recent weeks.

Data provided by the WHO indicates that approximately half of the 2,500 recorded deaths attributed to the current outbreak have occurred within just the last 20 days. This sharp increase has prompted international health agencies to prioritize the deployment of experimental vaccines to contain the spread and protect vulnerable populations in affected regions.

The situation remains critical as medical teams work to manage the influx of patients and implement containment strategies. The upcoming vaccine trial is viewed as a vital step in curbing the mortality rate, though officials emphasize that broader public health measures, including improved sanitation and contact tracing, remain essential to ending the outbreak. Further updates on the trial's progress and the overall epidemiological situation are expected as the WHO continues to monitor the region.